Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
Condition(s):Chronic Hepatitis CLast Updated:August 8, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Hepatitis CLast Updated:August 8, 2013Completed
Condition(s):COVID-19Last Updated:January 25, 2024Completed
Condition(s):Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Symptomatic COVID-19 Infection Laboratory-ConfirmedLast Updated:April 26, 2021Withdrawn
Condition(s):COVID-19 PneumoniaLast Updated:February 14, 2022Completed
Condition(s):Post COVID-19 Condition, Unspecified; SARS-CoV2 Infection; COVID-19Last Updated:October 18, 2023Recruiting
Condition(s):Hepatitis C; HCV; Chronic Hepatitis C Infection; Hepatitis C Genotype 1Last Updated:January 8, 2015Completed
Condition(s):COVID-19Last Updated:June 3, 2022Terminated
Condition(s):Chronic Hepatitis C; Hepatitis C (HCV); Hepatitis C Genotype 1aLast Updated:October 31, 2017Completed
Condition(s):Chronic Hepatitis C; Hepatitis C (HCV); Hepatitis C Genotype 1aLast Updated:October 3, 2017Completed
Condition(s):COVID-19Last Updated:March 14, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.